ENTRY       D01692                      Drug
NAME        Alfuzosin hydrochloride (JAN/USAN);
            Uroxatral (TN)
PRODUCT     UROXATRAL (Concordia Pharmaceuticals)
  GENERIC   ALFUZOSIN HYDROCHLORIDE (Aphena Pharma Solutions - Tennessee)
            ALFUZOSIN HYDROCHLORIDE (Apotex Corp.)
            ALFUZOSIN HYDROCHLORIDE (Aurobindo Pharma Limited)
            ALFUZOSIN HYDROCHLORIDE (Bryant Ranch Prepack)
            ALFUZOSIN HYDROCHLORIDE (Bryant Ranch Prepack)
            ALFUZOSIN HYDROCHLORIDE (Bryant Ranch Prepack)
            ALFUZOSIN HYDROCHLORIDE (Bryant Ranch Prepack)
            ALFUZOSIN HYDROCHLORIDE (Bryant Ranch Prepack)
            ALFUZOSIN HYDROCHLORIDE (Bryant Ranch Prepack)
            ALFUZOSIN HYDROCHLORIDE (Cipla USA)
            ALFUZOSIN HYDROCHLORIDE (Exelan Pharmaceuticals)
            ALFUZOSIN HYDROCHLORIDE (Golden State Medical Supply)
            ALFUZOSIN HYDROCHLORIDE (Northwind Pharmaceuticals)
            ALFUZOSIN HYDROCHLORIDE (Northwind Pharmaceuticals)
            ALFUZOSIN HYDROCHLORIDE (Northwind Pharmaceuticals)
            ALFUZOSIN HYDROCHLORIDE (Rising Health)
            ALFUZOSIN HYDROCHLORIDE (Sun Pharmaceutical Industries)
            ALFUZOSIN HYDROCHLORIDE (Unichem Pharmaceuticals (USA))
FORMULA     C19H27N5O4. HCl
EXACT_MASS  425.183
MOL_WEIGHT  425.9097
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG01465  alpha-Adrenergic receptor antagonist
               DG01457  alpha1-Adrenergic receptor antagonist
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: G04CA01
            Chemical structure group: DG00489
            Product (DG00489): D01692<US>
EFFICACY    Antidysuria, Antihypertensive, alpha1-Adrenergic receptor antagonist
COMMENT     Prazosin derivative
TARGET      ADRA1A [HSA:148] [KO:K04135]
  PATHWAY   hsa04022(148)  cGMP-PKG signaling pathway
            hsa04080(148)  Neuroactive ligand-receptor interaction
            hsa04270(148)  Vascular smooth muscle contraction
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G04 UROLOGICALS
               G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
                G04CA Alpha-adrenoreceptor antagonists
                 G04CA01 Alfuzosin
                  D01692  Alfuzosin hydrochloride (JAN/USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Genitourinary Agents
              Benign Prostatic Hypertrophy Agents
               Alfuzosin
                D01692  Alfuzosin hydrochloride (JAN/USAN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01457  alpha1-Adrenergic receptor antagonist
                 DG00489  Alfuzosin
                  D01692  Alfuzosin hydrochloride
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00489  Alfuzosin
                 D01692  Alfuzosin hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA1A
                 D01692  Alfuzosin hydrochloride (JAN/USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01692
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01692
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01692
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01457  alpha1-Adrenergic receptor antagonist
                 DG00489  Alfuzosin
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00489  Alfuzosin
DBLINKS     CAS: 81403-68-1
            PubChem: 7848755
            ChEBI: 32286
            LigandBox: D01692
            NIKKAJI: J346.511J
ATOM        29
            1   C8y C    21.4500  -13.4748
            2   C8y C    21.4500  -12.0658
            3   C8x C    22.6778  -14.1822
            4   C8y C    20.2397  -14.1822
            5   N5x N    20.2397  -11.3817
            6   C8x C    22.6778  -11.3817
            7   C8y C    23.8821  -13.4748
            8   N5x N    19.0294  -13.4748
            9   N1a N    20.2397  -15.5855
            10  C8y C    19.0294  -12.0658
            11  C8y C    23.8821  -12.0658
            12  O2a O    25.1158  -14.1822
            13  N1c N    17.8190  -11.3817
            14  O2a O    25.1158  -11.3817
            15  C1a C    26.3203  -13.4689
            16  C1b C    16.5970  -12.0658
            17  C1a C    26.3203  -12.0774
            18  C1a C    17.8219   -9.9828
            19  C1b C    15.3948  -11.3505
            20  C1b C    14.1744  -12.0339
            21  N1b N    12.9722  -11.3186
            22  C5a C    11.7517  -12.0019
            23  O5a O    11.7799  -13.4006
            24  C1y C    10.5565  -11.3311
            25  C1x C    10.1211  -10.0016
            26  O2x O     9.4217  -12.1564
            27  C1x C     8.2870  -11.3311
            28  C1x C     8.7223  -10.0016
            29  X   Cl   29.5439  -12.6330
BOND        30
            1     7  12 1
            2    10  13 1
            3    11  14 1
            4    12  15 1
            5    13  16 1
            6    14  17 1
            7     7  11 1
            8     8  10 1
            9    13  18 1
            10   16  19 1
            11    1   2 2
            12   19  20 1
            13    1   3 1
            14   20  21 1
            15    1   4 1
            16   21  22 1
            17    2   5 1
            18   22  23 2
            19    2   6 1
            20   22  24 1
            21    3   7 2
            22    4   8 2
            23    4   9 1
            24    5  10 2
            25   25  24 1
            26   24  26 1
            27   26  27 1
            28   27  28 1
            29   28  25 1
            30    6  11 2
///
